RxDoctor Payments DataLook up a doctor →

Stacy Smith, PA

Medical · Vero Beach, FLNPI 1316930886

Payments from drug & device makers

$49,041in general payments, 2019–2025

Across 615 payments — averaging $79.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$21K
  • Mallinckrodt Hospital Products Inc.$7K
  • AstraZeneca$5K
  • Biogen$2K
  • Eli Lilly$2K
  • EMD Serono, Inc.$1K
  • plus $9K from 51 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)76$21,131
Mallinckrodt Hospital Products Inc.33$7,056
AstraZeneca34$5,405
Biogen47$2,495
Eli Lilly4$2,053
EMD Serono, Inc.49$1,448
Argenx US, Inc.15$1,142
Amgen(2 entities)10$912
Novartis59$671
Lilly USA, LLC25$603
Pfizer23$531
Sanofi17$431
TG Therapeutics, Inc.9$415
Eisai Inc.11$392
Teva Pharmaceuticals USA, Inc.15$352
Bristol Myers Squibb13$302
Amneal Pharmaceuticals LLC17$281
UCB, Inc.8$266
Genentech USA, Inc.15$256
Sunovion Pharmaceuticals Inc.11$232
Takeda Pharmaceuticals U.S.A., Inc.7$231
MDD US Operations, LLC12$227
Lundbeck LLC9$207
CSL Behring8$205
Otsuka America Pharmaceutical, Inc.9$179
Merz Pharmaceuticals, LLC6$164
ANI Pharmaceuticals, Inc.5$138
Johnson & Johnson7$115
Sumitomo Pharma America, Inc.6$112
Tanabe Pharma America, Inc.5$101
Biohaven Pharmaceuticals, Inc.5$101
Upsher-smith Laboratories LLC5$95
Biohaven Pharmaceutical Holding Company Ltd.5$90
SK Life Science, Inc.3$76
Kyowa Kirin, Inc.3$72
C2n Diagnostics, LLC1$44
Alnylam Pharmaceuticals Inc.2$41
Corium, LLC3$40
Grifols USA, LLC2$40
Neurocrine Biosciences, Inc.2$39
Acorda Therapeutics, Inc2$39
Avanir Pharmaceuticals, Inc.2$35
Almatica Pharma LLC1$27
Xeris Pharmaceuticals, Inc.1$25
Neurelis, Inc.1$25
Axsome Therapeutics, Inc.1$24
Boston Scientific1$22
Cycle Pharmaceuticals Inc1$20
Banner Life Sciences, LLC1$20
Adamas Pharmaceuticals, Inc.1$20
Acadia Pharmaceuticals Inc1$17
Bio Products Laboratory USA, Inc.1$15
Insightec,inc1$15
Nevro Corp.1$14
Avion Pharmaceuticals1$13
Impel Pharmaceuticals Inc.1$12
Aucta Pharmaceuticals, Inc.1$11

How this compares

$49,041 in reported general payments places this provider in the 95th percentile of 2,031 medical providers in Florida.

See all medical providers in Florida

Medicare billing

Part B allowed, 2024
$239,434
Medicare patients
1,066
Services billed
2,477

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other medical in Vero Beach

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →